<?xml version="1.0" encoding="UTF-8"?><protocols retrieved="2016-04-29T09:00:22"><protocol><id>3582</id><accession>P-GSE10567-2</accession><name>P-GSE10567-2</name><text>ID_REF = &lt;br&gt;VALUE = fluorescence intensity&lt;br&gt;ABS_CALL = presence or absence call&lt;br&gt;DETECTION P-VALUE = confidence in precense call</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3591</id><accession>P-GSE1057-2</accession><name>P-GSE1057-2</name><text>ID_REF =  &lt;br&gt;FOLD_CHANGE = Balanced Differential Expression (Fold Change)&lt;br&gt;PROBE1 = Normal (P1 Signal, Cy5)&lt;br&gt;PROBE2 = Normal (P2 Balanced Signal, Cy3)&lt;br&gt;VALUE = log ratio (normal/normal)</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3587</id><accession>P-GSE10567-5</accession><name>P-GSE10567-5</name><text>Affymetrix protocol, O/N</text><type>hybridization</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3602</id><accession>P-GSE10572-8</accession><name>P-GSE10572-8</name><text>To obtain gene-specific signal intensity data, the raw value for lambda A (negative control) in the same block was subtracted.</text><type>feature_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3603</id><accession>P-GSE10572-12</accession><name>P-GSE10572-12</name><text>Total RNA of each subset of PBMCs derived from 10 ml of peripheral blood, was reverse-transcribed with oligo (dT) primer bearing a T7 promoter and transcribed in vitro to synthesize biotin-modified antisense RNA (aRNA) using MessageAmp II-Biotin Enhanced kit (Ambion), according to Mitsubishi Rayon’s protocol ver. 2.  For some specimens, which contained too few cells to obtain enough amount of aRNA for array hybridization by single round amplification, amplification was performed two rounds, using MessageAmp II aRNA Amplification Kit (Ambion) in addition to MessageAmp II-Biotin Enhanced kit, according to the manufacturer’s protocol.</text><type>labeling</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3604</id><accession>P-GSE10572-2</accession><name>P-GSE10572-2</name><text>Ten milliliter of peripheral blood was centrifuged over Histopaque 1077 (Sigma, St. Louis, USA) at 500 × g for 15 minutes to isolate mononuclear cells, which were then washed with RPMI 1640 media.  CD8+, CD56+, CD4+, and CD14+ cell subsets were isolated from the peripheral blood mononuclear cells (PBMCs) in this order by employing CD8 MicroBeads, CD56 MicroBeads, CD4 MicroBeads, and CD14 MicroBeads, respectively (Miltenyi Biotec GmbH, Germany), and then lyzed immediately in TRIZOL® reagent (Invitrogen, California, USA).  Total RNA was extracted and then purified using RNeasy® Micro kit (Qiagen, Valencia, CA) with on-column DNase digestion, according to the manufacturer’s protocol.</text><type>nucleic_acid_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3605</id><accession>P-GSE10572-6</accession><name>P-GSE10572-6</name><text>The arrays were then scanned to obtain images using a cooled CCD-type DNA chip image analyzer (Mitsubishi Rayon).  Fluorescent intensity of images was quantified automatically with the software developed by Mitsubishi Rayon Co., Ltd.</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3606</id><accession>P-GSE10572-13</accession><name>P-GSE10572-13</name><text>Hybridization was performed according to Mitsubishi Rayon’s protocol ver. 2.  Briefly, 10 μg of biotin-modified aRNA, which was fragmented using Fragmentation Reagents (Ambion), was suspended in buffer A1 containing 0.12 M Tris-HCl (pH 7.5), 0.12 M NaCl, and 0.05% Tween 20.  The hybridization mixture was heated to 94°C for 2 min, then cooled to 37°C and injected into a hybridization chamber (Mitsubishi Rayon).  Hybridization was carried out at 65°C for 16 hr with the chamber rotating slowly.  Microarrays were washed by soaking twice in buffer A1 at 65°C for 20 min, then once in buffer A2 containing 0.12 M Tris-HCl (pH 7.5) and 0.12 M NaCl, at 65°C for 10 min, and finally left at rest for 60 min at room temperature.  Microarrays were stained with 2 μg/ml Streptavidin-Cy5 (GE Healthcare) in buffer A2 at room temperature for 30 min, then washed 4 times by soaking in buffer A1 at room temperature each for 5 min.</text><type>hybridization</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3607</id><accession>P-GSE10572-14</accession><name>P-GSE10572-14</name><text>Finally, significance analysis of microarray (SAM) (Tusher VG et al. Proc Natl Acad Sci USA 98: 5116-5121, 2001) was carried out to evaluate differential gene expression during acute GVHD compared to recovery phase, with false discovery rate (FDR) lower than 10%, using &apos;samr&apos; package in R language.</text><type>feature_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3608</id><accession>P-GSE10572-11</accession><name>P-GSE10572-11</name><text>For each subset of PBMCs of a patient, paired samples (taken during acute GVHD (aGVHD(+)) versus taken upon discharge (aGVHD(−))) were handled in the same way and in parallel for every step of the following procedure, from total RNA extracting to scanning the arrays, according to Mitsubishi Rayon’s protocol ver. 2.</text><type>nucleic_acid_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3586</id><accession>P-GSE10567-6</accession><name>P-GSE10567-6</name><text>Affymetrix scanner 3000</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3568</id><accession>P-GSE10561-2</accession><name>P-GSE10561-2</name><text>ID_REF = 251339410080&lt;br&gt;VALUE = normalized log2 ratios of medians defined as normalized Ch2 divided by Ch1&lt;br&gt;Ch1_Median = Channel 1 median intensity&lt;br&gt;Ch2_Median = Channel 2 median intensity</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3572</id><accession>P-10563-3</accession><name>P-10563-3</name><text>Trizol extraction of total RNA was performed according to the manufacturer&apos;s instructions.</text><type>nucleic_acid_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3573</id><accession>P-10563-2</accession><name>P-10563-2</name><text>Biotinylated cRNA were prepared according to the standard Affymetrix protocol</text><type>labeling</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3574</id><accession>P-10563-1</accession><name>P-10563-1</name><text>Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.</text><type>hybridization</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3578</id><accession>P-10565-3</accession><name>P-10565-3</name><text>Trizol extraction of total RNA was performed according to the manufacturer&apos;s instructions.</text><type>nucleic_acid_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3579</id><accession>P-10565-1</accession><name>P-10565-1</name><text>Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.</text><type>hybridization</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3580</id><accession>P-10565-2</accession><name>P-10565-2</name><text>Biotinylated cRNA were prepared according to the standard Affymetrix protocol</text><type>labeling</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3699</id><accession>P-GSE10590-16</accession><name>P-GSE10590-16</name><text>The algorithm&apos;s quality metrics “flags” and the ratio of signal/noise were used, on each microarray, to quantify probe quality and detectability (1700 Chemiluminescent Microarray Analyzer Users Guide). Probes with a signal/noise ratio &lt;3 and/or flags &gt;5,000 were excluded. From the initial 32,878 probeset, 15,308 high-quality probes were kept, and their signal were normalized among arrays by using the quantile technique</text><type>feature_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3700</id><accession>P-GSE10590-7</accession><name>P-GSE10590-7</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/8a-1_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3701</id><accession>P-GSE10590-14</accession><name>P-GSE10590-14</name><text>Microarrays were prehybridized during 1h at 55ºC. During prehybridization, 10 micrograms of DIG-labeled cRNA were fragmented and used for hybridization (55 ºC, 16 h, 100 rpm agitation), according to Applied Biosystems Chemiluminescence Detection Kit. Same manufacturer´s protocol was used for hybridization washes and for performing Antibody Binding (anti-digoxigenin-AP) and antibody washes. The next steps, chemiluminescent reaction and detection, were performed with only one microarray at a time and following manufactures´ procedures.</text><type>hybridization</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3702</id><accession>P-GSE10590-12</accession><name>P-GSE10590-12</name><text>Blood was collected at 8 a.m., at fasting state, prior to first (0 hours, pre-dose), 6 h after acute (50 ml (44 g) virgine olive oil) and at 8 a.m., at fasting state, after 3-weeks (25 ml (22 g) virgine olive oil per day) interventions. Periferal Blood Mononuclear Cells (PBMCs) were isolated within two hours after blood drawing using Vacuntainer CPT tubes (Beckton Dickinson, Franklin Lakes, NJ, USA) and following manufacturer´ instructions. Harvested PMNCs were preserved in 1 ml of Ultraspec solution (Biotecx Laboratories, Houston, TX, USA) and were stored at -80ºC prior to RNA extraction. Total RNA was extracted from Ultraspec preserved PMNCs following manufacturer´instructions. RNA concentration (A260) and RNA purity (A260/A280 and A260/A280 ratios) were estimated spectrometrically (NanoDrop® ND-1000, NanoDrop Technologies, USA). RNA integrity was assessed by micro capillary gel electrophoresis (Bioanalyzer, NanoChip, Agilent Technologies, Wilmington, DE, USA) and was estimated by both the rRNA ratio (28S/18S rRNA ratio) and the RIN value (RNA integrity number) using Agilent 2100 Expert Software . The purity of isolated individual RNA samples was greater than 1.8 by A260/A280 and 1.75 by A260/A280, with integrity values not lower than 1.7 and 8.5 by 28S/18S rRNA ratio and by RIN, respectively.The weight equivalents of individual total RNA samples corresponding to baseline, acute and to 3-week intervention were combined into three RNA pooles, respectively. The pooled RNA samples were concentrated using the Rneasy Mini Elute Cleanup system (Qiagen, Barcelona, Spain), till the required by microarray service concentration (0.1 μg/μl). The prepared RNA pools had purity not lower than 1.9 by both A260/A280 and A260/A280 ratios and the integrity was at score of 9.0 according to RIN.The aliquoted pooled and individual RNAs samples were stored at -80º C prior to use.</text><type>nucleic_acid_extraction</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3703</id><accession>P-GSE10590-9</accession><name>P-GSE10590-9</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/8a-3_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3704</id><accession>P-GSE10590-15</accession><name>P-GSE10590-15</name><text>Microarrays were scanned with the Applied Biosystems 1700 Chemiluminescent Analyzer and quantified using the AB1700 software</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3705</id><accession>P-GSE10590-10</accession><name>P-GSE10590-10</name><text>At first intervention day, at fasting state, 50 mL (44 g) of virgin olive oil were administered in a single dose (experiment 1), following this, volunteers continued with consumption of 25 ml (22 g) of virgin olive oil per day during 3 consequent weeks (experiment 2).</text><type>specified_biomaterial_action</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3706</id><accession>P-GSE10590-2</accession><name>P-GSE10590-2</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/2a-2_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3707</id><accession>P-GSE10590-13</accession><name>P-GSE10590-13</name><text>One microgram of total RNA was reverse-transcribed using T7-oligo (dT) primer. After first and second strand cDNA synthesis, the cDNA was purified and used for in vitro transcription (IVT) labeling with DIG-UTP, rendering labeled cRNA, according to the Applied Biosystems instructions for Chemiluminescent RT-IVT labeling kit V.2.0.</text><type>labeling</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3708</id><accession>P-GSE10590-11</accession><name>P-GSE10590-11</name><text>Prior to the intervention, volunteers followed a one week washout period in which sunflower oil was provided as a source of fat for all purposes. During the first four days of the washout period, participants were asked to follow an antioxidant-controlled diet. Participants were allowed to eat per day less than: 2 pieces of fruit, 2 servings of vegetables or legumes, 2 cups of tea or coffee, and to avoid wine, beer, and olive oil consumption. During the last 3 days before, and on the intervention day, volunteers followed a strict low-phenolic compound diet., according to which  several foods, rich in phenolic compounds, were excluded from their diet (vegetables, legumes, fruit, juice, wine, coffee, tea, caffeine-containing soft drinks, beer, cacao, marmalade, olive oil and olives).</text><type>grow</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3709</id><accession>P-GSE10590-5</accession><name>P-GSE10590-5</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/4a-2_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3710</id><accession>P-GSE10590-1</accession><name>P-GSE10590-1</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/2a-1_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3711</id><accession>P-GSE10590-8</accession><name>P-GSE10590-8</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/8a-2_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3712</id><accession>P-GSE10590-6</accession><name>P-GSE10590-6</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/4a-3_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3713</id><accession>P-GSE10590-3</accession><name>P-GSE10590-3</name><text>ID_REF = &lt;br&gt;VALUE = AB1700 software fully corrected signal intensity&lt;br&gt;S_N_P/2a-3_OKhymenets_220905 =</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>3718</id><accession>P-G10592-3</accession><name>P-G10592-3</name><text>Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 7 mug total RNA (Expression analysis technical manual, Affymetrix).</text><type>labeling</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>561527</id><accession>P-GSE7618-39</accession><name>P-GSE7618-39</name><text>not provided Feature Extraction; Software and parameters for feature extraction.; Protocol Type = Feature Extraction; Parameter Image Origin = 960, 11520; Parameter Datafile type = GenePix Results 1.4; Software: type: feature extraction; Performer: Nina,,Salama Scanning parameters - Channel 1; Parameters for laser scanning of a hybridized array in channel 1.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 33.25; Parameter Scan Time = 10:12:09; Parameter PMT Volts = 480; Parameter Scan Date = 2002-11-07; Parameter Pixel Size = 10; Parameter Laser on time = 62106; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [83966]; Parameter Laser Power = 3.60; Parameter Scan Power = 100; Parameter Scanning software version = 2.0.2.2; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama Scanning parameters - Channel 2; Parameters for laser scanning of a hybridized array in channel 2.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 33.25; Parameter Scan Time = 10:12:09; Parameter PMT Volts = 580; Parameter Scan Date = 2002-11-07; Parameter Pixel Size = 10; Parameter Laser on time = 59625; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [83966]; Parameter Laser Power = 3.66; Parameter Scanning software version = 2.0.2.2; Parameter Scan Power = 100; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol/></protocol><protocol><id>561528</id><accession>P-GSE7618-18</accession><name>P-GSE7618-18</name><text>not provided Feature Extraction; Software and parameters for feature extraction.; Protocol Type = Feature Extraction; Parameter Image Origin = 1960, 9080; Parameter Datafile type = GenePix Results 3; Software: type: feature extraction; Performer: Nina,,Salama Scanning parameters - Channel 1; Parameters for laser scanning of a hybridized array in channel 1.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 31.76; Parameter Scan Time = 10:55:11; Parameter PMT Volts = 600; Parameter Scan Date = 2004-12-13; Parameter Pixel Size = 10; Parameter Laser on time = 55003; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [92865]; Parameter Laser Power = 3.60; Parameter Scan Power = 100; Parameter Scanning software version = 2.0.3.1; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama Scanning parameters - Channel 2; Parameters for laser scanning of a hybridized array in channel 2.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 31.76; Parameter Scan Time = 10:55:11; Parameter PMT Volts = 600; Parameter Scan Date = 2004-12-13; Parameter Pixel Size = 10; Parameter Laser on time = 54678; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [92865]; Parameter Laser Power = 3.78; Parameter Scanning software version = 2.0.3.1; Parameter Scan Power = 100; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol/></protocol><protocol><id>561529</id><accession>P-GSE7618-17</accession><name>P-GSE7618-17</name><text>not provided Feature Extraction; Software and parameters for feature extraction.; Protocol Type = Feature Extraction; Parameter Image Origin = 2480, 35720; Parameter Datafile type = GenePix Results 3; Software: type: feature extraction; Performer: Nina,,Salama Scanning parameters - Channel 1; Parameters for laser scanning of a hybridized array in channel 1.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 32.03; Parameter Scan Time = 17:14:31; Parameter PMT Volts = 790; Parameter Scan Date = 2004-11-27; Parameter Pixel Size = 10; Parameter Laser on time = 54216; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [92865]; Parameter Laser Power = 5.91; Parameter Scan Power = 10; Parameter Scanning software version = 2.0.3.1; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama Scanning parameters - Channel 2; Parameters for laser scanning of a hybridized array in channel 2.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 32.03; Parameter Scan Time = 17:14:31; Parameter PMT Volts = 630; Parameter Scan Date = 2004-11-27; Parameter Pixel Size = 10; Parameter Laser on time = 53993; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [92865]; Parameter Laser Power = 3.79; Parameter Scanning software version = 2.0.3.1; Parameter Scan Power = 33; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol/></protocol><protocol><id>561526</id><accession>P-GSE7618-19</accession><name>P-GSE7618-19</name><text>not provided Feature Extraction; Software and parameters for feature extraction.; Protocol Type = Feature Extraction; Parameter Image Origin = 1840, 9130; Parameter Datafile type = GenePix Results 3; Software: type: feature extraction; Performer: Nina,,Salama Scanning parameters - Channel 1; Parameters for laser scanning of a hybridized array in channel 1.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 32.55; Parameter Scan Time = 11:45:51; Parameter PMT Volts = 630; Parameter Scan Date = 2006-06-09; Parameter Pixel Size = 10; Parameter Laser on time = 86935; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [92865]; Parameter Laser Power = 3.47; Parameter Scan Power = 100; Parameter Scanning software version = 2.0.3.2; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama Scanning parameters - Channel 2; Parameters for laser scanning of a hybridized array in channel 2.; Protocol Type = Scanning parameters; Parameter Scanner Make = Axon Instruments (V1.00); Parameter Scan Temperature = 32.55; Parameter Scan Time = 11:45:51; Parameter PMT Volts = 760; Parameter Scan Date = 2006-06-09; Parameter Pixel Size = 10; Parameter Laser on time = 87362; Parameter Focus Position = 0; Parameter Scanner Model = GenePix 4000B [92865]; Parameter Laser Power = 3.65; Parameter Scanning software version = 2.0.3.2; Parameter Scan Power = 100; Parameter Scanning software = AxImageIO; Performer: Nina,,Salama</text><type>image_aquisition</type><performer/><hardware/><software/><standardpublicprotocol/></protocol><protocol><id>4279</id><accession>P-GSE10681-11</accession><name>P-GSE10681-11</name><text>ID_REF = &lt;br&gt;VALUE = background corrected and normalized log2-ratio (DBM 8h rep3/control)&lt;br&gt;CH1_MEDIAN = Median pixel intensity of foreground in channel 1 (control 8h rep 3, Cy3, ImaGene)&lt;br&gt;CH1_BCK = Median pixel intensity of background in channel 1 (control 8h rep 3, Cy3, ImaGene)&lt;br&gt;CH2_MEDIAN = Median pixel intensity of foreground in channel 2 (DBM 8h rep 3, Cy5, ImaGene)&lt;br&gt;CH2_BCK = Median pixel intensity of background in channel 2 (DBM 8h rep 3, Cy5, ImaGene)&lt;br&gt;FLAG = flag=0: good spot (ImaGene), flag=1: manually flagged, flag=2: poor spot (ImaGene)</text><type>bioassay_data_transformation</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol><protocol><id>4280</id><accession>P-GSE10681-18</accession><name>P-GSE10681-18</name><text>Arabidopsis thaliana plants (ecotype Landsberg erecta) were grown in plastic pots (10cm wide x 8cm tall) containing Terra-lite Redi-earth (W.R. Grace and Co., Ajax, Ontario, Canada).  Each pot contained four or five plants, which were grown in a growth chamber (Controlled Environment Ltd., Winnipeg, MB, Canada) at 20˚C constant temperature, 8 hr/16 hr Light/Dark photoperiod at 50-60% ambient humidity, for 8 to 9 weeks.  Short day conditions prevented the onset of flowering and the plants were thus maintained in growth stage 1 (leaf production) with 13 to 15 rosette leaves larger than 1mm (stage 1.13 to 1.14).</text><type>grow</type><performer/><hardware/><software/><standardpublicprotocol>0</standardpublicprotocol></protocol></protocols>
